Details for Patent: 8,445,515
✉ Email this page to a colleague
Which drugs does patent 8,445,515 protect, and when does it expire?
Patent 8,445,515 protects TAVNEOS and is included in one NDA.
This patent has sixty-nine patent family members in thirty-six countries.
Summary for Patent: 8,445,515
| Title: | C5aR antagonists |
| Abstract: | Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors. |
| Inventor(s): | Pingchen Fan, Kevin Lloyd Greenman, Manmohan Reddy Leleti, Yandong Li, Jay Powers, Hiroko Tanaka, Ju Yang, Yibin Zeng |
| Assignee: | Chemocentryx Inc |
| Application Number: | US12/643,229 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,445,515 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,445,515
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemocentryx | TAVNEOS | avacopan | CAPSULE;ORAL | 214487-001 | Oct 7, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,445,515
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2381778 | ⤷ Start Trial | 301166 | Netherlands | ⤷ Start Trial |
| European Patent Office | 3508477 | ⤷ Start Trial | PA2022006 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2381778 | ⤷ Start Trial | 2022C/518 | Belgium | ⤷ Start Trial |
| European Patent Office | 2381778 | ⤷ Start Trial | LUC00258 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2381778 | ⤷ Start Trial | CA 2022 00022 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
